Dr. Falutz is Associate Professor of Medicine at McGill University, and a Senior Physician in the Division of Geriatrics at the McGill University Health Center. He attended McGill University School of Medicine and completed his residency in general internal medicine with subspecialty training in internal medicine and geriatrics. He is actively involved in the clinical care of HIV-infected persons and HIV related clinical research. He is Director of the Comprehensive HIV and Aging Initiative of the Chronic Viral Illness Service at the McGill University Hospital Center.
Dr. Falutz has initiated and continues to be a collaborator in clinical studies related to metabolic complications in persons living with HIV. His research focus is on frailty and geriatric syndromes in persons aging with HIV. He is involved in a leading capacity in the interdisciplinary assessment and management of geriatric syndromes and comorbidities in persons aging with HIV.
He was a co-principal investigator in studies of a novel recombinant human growth hormone releasing factor, tesamorelin, as treatment for HIV/HAART associated visceral adiposity. He is an investigator and coordinator for the Canadian involvement in the recently completed and published REPRIEVE (Randomized Trial to Prevent Vascular Events in HIV) Study.
